Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir.

Published in: JMIR public health and surveillance (2020)

Based on the statistical issues and lessons learned from the recent three clinical trials on COVID-19 treatments, we suggest more appropriate approaches for the design and analysis of ongoing and future COVID-19 trials.

Keyphrases

coronavirus disease
sars cov
clinical trial
respiratory syndrome coronavirus
randomized controlled trial
phase ii
current status
open label
antiretroviral therapy